>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • ATKR -9.7%, MRK -7.9%, EL -7%, FN -6.9% (also approves another $100 mln for repurchases), PYPL -6.6%, UBS -6.1%, SYNA -5.3% (also appoints interim CEO), VOD -5.1%, PNR -4.5%, WWD -3.9% (also increases dividend), CNH -3.5%, OCSL -3.4%, AME -3.2%, CLX -2.8%, PEP -2.2%, JJSF -2%, INGR -2%, ENR -1.9%, TDG -1.2%, DEO -1%
Other news:
  • BCTX -20.8% (stock offering)
  • TBBB -4.6% (stock offering)
  • ANRO -3.1% $300 mln mixed shelf)
  • UFI -3% (announces manufacturing transition)
  • IR -1% (acquires SSI Aeration)
  • CIFR -0.9% (January operational update)
  • D -0.8% (provides update on Coastal Virginia Offshore Wind project)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • PLTR +21.9%, SPOT +8.9%, FLXS +6.8%, AXTA +5.4%, IT +3.7%, REGN +3.7%, ARMK +3.5%, RYAM +3.1%, APO +2.9%, BRBR +2.8%, PJT +2.8%, RACE +2.6%, AUDC +2.4%, SNCY +2%, PFE +2%, KFRC +1.9%, LITE +1.7% (also appoints new CEO), MTG +1.6%, BALL +1.6%, J +1.6%, GETY +1.6%, AMCR +1.4%, MPC +1.4%, CSWC +1.2%, FLNG +1.1%,
Other news:
  • TEM +6.4% (completes acqusition of Ambry Genetics)
  • KALV +5.9% (Venrock increased passive stake to 10.1% following the purchase of 70,023 shares)
  • SIRI +3% (Berkshire Hathaway (BRK.A / BRK.B) bought another 2,308,119 shares at $22.24 - $24.225 worth nearly $54 mln)
  • SEI +2.7% (stock offering)
  • LWAY +1.9% (Edward and Ludmila Smolyansky Request Lifeway Foods Inc. NASDAQ (LWAY) CEO Julie Smolyansky Immediately Withdraws Her Lawsuit Against Edward Smolyansky. Reiterate and Reaffirm Singular Goal Amid Ongoing Activism Battle)
  • LBRT +1.4% (names Ron Gusek as CEO)
  • AVAV +1% (secures U.S. Army contract)

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • AMC Entertainment (AMC) upgraded to Neutral from Sell at ROTH MKM; tgt lowered to $3.25
    • Aptiv (APTV) upgraded to Buy from Hold at HSBC Securities; tgt raised to $77
    • Bank of Princeton (BPRN) upgraded to Buy from Neutral at Janney; tgt $35
    • Grab (GRAB) upgraded to Buy from Hold at HSBC Securities; tgt lowered to $5.45
    • Juniper Networks (JNPR) upgraded to Outperform from In-line at Evercore ISI; tgt $40
    • Marriott (MAR) upgraded to Outperform from In-line at Evercore ISI; tgt $330
    • Mastercard (MA) upgraded to Buy from Hold at DZ Bank; tgt $620
    • Novartis AG (NVS) upgraded to Buy from Hold at Deutsche Bank
    • Palantir Technologies (PLTR) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $95
    • Treace Medical Concepts (TMCI) upgraded to Buy from Neutral at BTIG Research; tgt $16
    • Tyson Foods (TSN) upgraded to Neutral from Underweight at Piper Sandler
  • Downgrades:
    • American Woodmark (AMWD) downgraded to Peer Perform from Outperform at Wolfe Research
    • Amphastar Pharmaceuticals (AMPH) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $36
    • Autoliv (ALV) downgraded to Hold from Buy at HSBC Securities; tgt lowered to $100
    • Brilliant Earth Group (BRLT) downgraded to Hold from Buy at Jefferies; tgt lowered to $1.60
    • Calumet Specialty Products (CLMT) downgraded to Sell from Neutral at UBS; tgt lowered to $15
    • Napco Security Systems (NSSC) downgraded to Hold from Buy at TD Cowen; tgt lowered to $27
    • Ollie's Bargain Outlet (OLLI) downgraded to Hold from Buy at Jefferies; tgt lowered to $111
    • Olin (OLN) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $30
    • Triumph Group (TGI) downgraded to Neutral from Outperform at Robert W. Baird; tgt raised to $26
  • Others:
    • 89bio (ETNB) initiated with an Outperform at Wolfe Research
    • AnaptysBio (ANAB) initiated with an Outperform at Wolfe Research; tgt $25
    • Catalyst Pharma (CPRX) initiated with an Outperform at Robert W. Baird; tgt $28
    • Celestica (CLS) resumed with a Buy at Stifel; tgt $140
    • Crinetics Pharmaceuticals (CRNX) initiated with a Peer Perform at Wolfe Research
    • Expand Energy Corporation (EXE) initiated with a Strong Buy at Raymond James; tgt $135
    • Oruka Therapeutics (ORKA) initiated with an Outperform at Wolfe Research; tgt $20
    • Plexus (PLXS) resumed with a Hold at Stifel; tgt $152
    • Terreno Realty (TRNO) initiated with a Market Perform at BMO Capital Markets; tgt $71
    • Venture Global (VG) initiated with a Mkt Perform at Bernstein; tgt $20
    • Vera Therapeutics (VERA) initiated with an Outperform at Wolfe Research; tgt $49
    • Zenas Biopharma (ZBIO) initiated with an Outperform at Wolfe Research; tgt $19

>>> Pfizer beats by $0.16, beats on revs; reaffirms FY25 EPS guidance, revs guid

Pfizer beats by $0.16, beats on revs; reaffirms FY25 EPS guidance, revs guidance (26.20)
  • Reports Q4 (Dec) earnings of $0.63 per share, excluding non-recurring items, $0.16 better than the FactSet Consensus of $0.47; revenues rose 24.7% year/year to $17.76 bln vs the $17.39 bln FactSet Consensus.
  • Excluding contributions from Comirnaty and Paxlovid, fourth-quarter 2024 operational revenue growth was driven primarily by:
    • Global revenues of $915 million from legacy Seagen compared with $132 million of revenue in fourth-quarter 2023 following the completion of the acquisition in mid-December 2023;
    • Vyndaqel family (Vyndaqel, Vyndamax, Vynmac) globally, up 60% operationally, driven largely by strong demand with continuing uptake in patient diagnosis, primarily in the U.S. and international developed markets, as well as increased affordability in the U.S;
    • Eliquis globally, up 13% operationally, driven primarily by continued oral anti-coagulant adoption and market share gains in the non-valvular atrial fibrillation indication in the U.S. and certain markets in Europe, partially offset by declines due to loss of patent-based exclusivity and generic competition in certain international markets
  • Co reaffirms guidance for FY25, sees EPS of $2.80-$3.00, excluding non-recurring items, vs. $2.91 FactSet Consensus; sees FY25 revs of $61.0-$64.0 bln vs. $63.07 bln FactSet Consensus.

>>> Estee Lauder beats by $0.30, reports revs in-line; guides Q3 EPS below conse

Estee Lauder beats by $0.30, reports revs in-line; guides Q3 EPS below consensus, revs below consensus; expands restructuring
  • Reports Q2 (Dec) earnings of $0.62 per share, excluding non-recurring items, $0.30 better than the FactSet Consensus of $0.32; revenues fell 6.4% year/year to $4 bln vs the $3.98 bln FactSet Consensus.
  • Co issues downside guidance for Q3, sees EPS of $0.20 to $0.30, excluding non-recurring items, vs. $0.63 FactSet Consensus; sees Q3 revs of -12 to -10% yr/yr or $3.467 bln to $3.546 bln vs. $3.67 bln FactSet Consensus.
  • "Today, the Company announced it is also significantly expanding the restructuring component of the PRGP. Once fully implemented, the Company expects to take restructuring and other charges of between $1.2 billion and $1.6 billion, before taxes, consisting of employee-related costs, contract terminations, asset write-offs, and other costs associated with implementing these initiatives. The restructuring program is expected to yield annual gross benefits of between $0.8 billion and $1.0 billion, before taxes, to help restore operating margin and also fuel reinvestment in consumer facing areas to drive sustainable sales growth."

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • PLTR +19.8%, TEM +7.1%, KFRC +4.2%, CNC +3.7%, AUDC +3.6%, RYAM +3.1%, AXTA +2.9%, BRBR +2.8%, LITE +2.7%, RMBS +1.9%, EVTL +1.8%, AMCR +1.8%, CSWC +1.6%, LBRT +1.2%, IT +1.1%, MTG +1%, AVAV +0.8%, NEU +0.8%, CBT +0.7%, NXPI +0.7%
  • Gapping down:
    • BCTX -19.8%, UBS -5.6%, SYNA -5%, VOD -4%, FN -3.8%, TBBB -3.1%, ANRO -3.1%, UFI -3%, LWAY -3%, JJSF -2.1%, CIFR -1.7%, WWD -1.5%, CLX -1.3%, IR -1.1%, DEO -1.1%, BALL -1.1%, ROAD -0.9%, CPAY -0.9%, AMG -0.9%

FT : Nigel Farage’s Reform UK overtakes Labour in new opinion poll

Nigel Farage’s Reform UK overtakes Labour in new opinion poll
Survey will alarm ruling party and the Tories ahead of local elections in May

Reform UK has taken the lead in a British opinion poll for the first time, in a move that will alarm Labour and the Conservatives ahead of local elections in May.

Public support for Reform UK, the rightwing populist party led by Nigel Farage, was up 2 percentage points to 25 per cent, according to the YouGov survey.

Sir Keir Starmer’s ruling Labour party was down 3 points to 24 per cent, while the Conservatives slipped 1 point to 21 per cent.

YouGov said it was the first time its survey for The Times had shown Reform UK in front, although with a lead of just 1 point over Labour this was “within the margin of error”.

Opinion polls less than 12 months into a five-year parliament are rarely an accurate predictor of how people will vote at the next general election.

But Reform UK’s strong showing will ring alarm bells in Downing Street ahead of May’s local elections in England, with Starmer struggling to neutralise the populist party’s messages.

Farage’s party would introduce tougher immigration controls and is opposed to Britain’s climate targets, including reaching net zero carbon emissions by 2050.

Anthony Wells, head of European political and social research at YouGov, said the poll suggested three parties were vying for the lead.

“While it remains within the margins of error it reinforces the fact that Reform is roughly equal in support with Labour, with the Conservatives slipping back again,” he added.

Senior ministers believe they can win back public support if they can show progress on priorities such as cutting NHS hospital waiting lists and increasing housebuilding.

But Farage’s party, which has five MPs, appears to be benefiting from a growing anti-establishment mood across many western nations.

Reform UK has been praised by Elon Musk, the technology billionaire and close confidant of US President Donald Trump, who has repeatedly criticised Starmer.

Farage said in December that Musk was considering making a donation to Reform UK, but the two men have since clashed over the entrepreneur’s support for far-right activist Tommy Robinson.

On Tuesday, Farage told the BBC: “Elon Musk has an awful lot of opinions, some of which I agree with, some of which I don’t.”

Last week a “mega-poll” of almost 18,000 voters commissioned by campaign group Hope Not Hate, and carried out by Focaldata, suggested Reform UK would win 76 seats if a general election was held immediately, including 60 currently held by Labour.

The same survey indicated a 3 percentage point swing towards Reform UK from both Labour and the Tories which could result in it securing 169 seats.

The YouGov poll suggested Farage’s party was more popular among men, those of working-class backgrounds, and Brexit supporting voters.

The survey found Reform UK enjoyed its strongest support in the Midlands and northern England, with the party on just 13 per cent in London.

The poll recorded that backing for the Liberal Democrats and Greens was unchanged at 14 per cent and 9 per cent respectively.

Separately on Tuesday, YouGov brought back co-founder and former boss Stephan Shakespeare to replace chief executive Steve Hatch on an interim basis while it kicked off a search for a permanent replacement. 

The research and data analytics group said that Hatch’s departure was “mutually agreed”, although he has only served 18 months in the role and has faced calls to stand down by activist investor Gatemore Capital after shares dropped 70 per cent over the past year.

Shakespeare is non-executive chair of the board and still a major shareholder.

WSJ : Tariffs Give U.S. Steelmakers a Green Light to Lift Prices

Tariffs Give U.S. Steelmakers a Green Light to Lift Prices
Manufacturers face the prospect of higher costs for steel and aluminum despite Trump’s delay of tariff order

Steel prices started rising for some U.S. companies even before President Trump announced tariffs on Canada and Mexico. Executives said they are bracing for more to come.

Trump on Saturday announced 25% tariffs on all imports from Mexico and Canada starting Tuesday. On Monday, he said he would hold off for a month as talks got under way between the U.S. and its neighbors.

If implemented, the duties are expected to strengthen U.S. steelmakers’ pricing power by effectively raising prices for foreign steel. It could also enable domestic companies to raise their prices, too.

At Riverdale Mills, a Massachusetts-based manufacturer of wire fencing and welded mesh used in lobster and crab traps, Chief Executive James Knott said his domestic suppliers of steel wire rod notified him two weeks ago that they are raising prices.

Knott said he has been buying about 80% of Riverdale’s wire rod from Canada because shipping costs are lower to the East Coast than buying from mills in South Carolina, Texas and Illinois. Steel represents two-thirds of Riverdale’s production costs, and he said higher prices would put his company at a disadvantage versus foreign competitors.

“We like to use U.S. steel, but if you can’t buy the steel at the right price, you can’t compete,” Knott said. “The U.S. has the highest-priced steel.”

Canada and Mexico are two of the largest suppliers of imported steel to the U.S., accounting for 35% of all imported steel in 2024, according to the American Iron and Steel Institute and the Census Bureau. The two countries were included in steel and aluminum tariffs imposed during Trump’s first term in 2018, but they were later exempted in exchange for negotiating a new free-trade agreement with the U.S.

Executives from U.S. steel companies were enthusiastic backers of the tariffs and have urged Trump to deploy them again in his second term. They have called for eliminating tariff exemptions and duty-free import quotas, saying those carve-outs allow unfairly low-price steel to enter the U.S. and undermine the steel market.

Trump’s Saturday announcement of the duties included a 10% tariff on imports from China. The Trump administration has said the tariffs would help prod Mexico, Canada and China to crack down on illegal immigration and illicit fentanyl shipments into the U.S. Canada and Mexico have vowed to retaliate with their own tariffs, setting the stage for a North American trade war.

For consumers already reeling from rising retail prices and inflation, pricier steel and aluminum could further lift costs for durable goods like appliances and automobiles, as well as consumer products with aluminum packaging, such as canned beverages.

“We’re all going to get a price increase,” said Ralph Hardt, owner of Belleville International, a Pennsylvania-based manufacturer of valves and components used in the energy and defense industries. Steel and aluminum are Belleville’s largest expenses.

U.S. Steel announced a $50-a-ton price increase for flat-rolled steel this week, and Nucor NUE 2.23%increase; green up pointing triangle has raised its price by $25 a ton over the past two weeks, according to steel customers.

Trump administration tariffs on aluminum from Canada and Mexico would get absorbed in the U.S. through a delivery surcharge attached to all aluminum transactions. The higher charge could be a windfall for U.S. aluminum companies that don’t have to pay the tariff but get to collect a higher delivery premium from customers as if they did.

Beverage companies strongly opposed the Trump administration’s 10% tariff on imported aluminum in 2018. The industry complained that beer and soda makers paid delivery premiums above what was warranted to cover the tariff.

Canada is the U.S.’s largest supplier of aluminum made in smelters, sending 2.8 million metric tons to the U.S. in 2023, according to industry data.

Canada is home to about 40% of aluminum maker Alcoa’s AA -3.43%decrease; red down pointing triangle production capacity. The company said it would likely divert shipments from Canada to other countries to avoid paying a U.S. tariff.

The U.S. steel industry is coming off its weakest year since 2020, when the Covid-19 pandemic temporarily idled production. Spot market prices for coiled sheet steel have been mostly stuck below $700 for months.

Several attempts by steel companies to raise prices failed last year because of weak demand from buyers, including the automotive, construction, appliance and machinery industries.

“Manufacturing right now isn’t very robust, but the supply is certainly there because of all the mill capacity that has been built,” said Jim Barnett, CEO of Grand Steel Products, a Michigan-based steel distributor.

Over the past four years, nearly 12 million tons of additional annual capacity to make flat-rolled steel has been completed or is under construction in the U.S., according to commodity-markets research firm Argus Media. Steel executives trace the buildout’s origins to the first Trump administration’s tariffs, which boosted steelmakers’ profits and provided confidence to invest in more U.S. production.

Now they are counting on additional tariffs to squeeze more imports out of the U.S. steel market.

“You’re going to see those bad actors that are distorting how they price goods penalized,” said Leon Topalian, CEO of U.S. steel industry leader Nucor, on a late January conference call.

>>> Europe : Brokers Upgrades & Downgrades - 4th of February 2025 V2(+)

>>> Up
* Avanza Raised to Neutral at JPMorgan; PT 279 kronor
* AXA PT Raised to 46 euros from 41.50 euros at Berenberg
* Biophytis SA Raised to Buy at Invest Securities SA (+)
* Dunelm Raised to Outperform at RBC; PT 1,175 pence
* Melia Hotels Raised to Buy at JB Capital Markets; PT 9.50 euros
* Novartis Raised to Buy at Deutsche Bank; PT 110 Swiss francs
* Palantir Raised to Equal-Weight at Morgan Stanley; PT $95
* Pennon Raised to Outperform at RBC; PT 600 pence
* Syensqo Raised to Overweight at Morgan Stanley; PT 89 euros

>>> Down
* Autoliv GDRs Cut to Hold at Pareto Securities; PT 1,150 kronor
* Autoliv Cut to Hold at HSBC; PT $100
* Bavarian Nordic Cut to Hold at Nordea
* Fevertree Drinks Cut to Sell at Redburn; PT 593 pence
* Kalmar Cut to Hold at SEB Equities; PT 35 euros
* Lagercrantz Cut to Market Perform at Handelsbanken
* Orion Cut to Hold at Nordea
* QT Group Cut to Accumulate at Inderes; PT 90 euros
* Reckitt Cut to Equal-Weight at Barclays; PT 5,360 pence
* SSP Cut to Sector Perform at RBC; PT 200 pence
* Vaisala Cut to Accumulate at Evli Bank; PT 56 euros (+)
* Vitrolife Cut to Underperform at Handelsbanken; PT 255 kronor
* Vontobel Cut to Neutral at Oddo BHF; PT 66 Swiss francs

>>> Initiation
* Avanza Rated New Buy at Pareto Securities; PT 380 kronor
* Mycronic Rated New Buy at SEB Equities; PT 520 kronor
* Nordnet Rated New Hold at Pareto Securities; PT 265 kronor
* NOVAL GA Rated New Buy at Alpha Finance; PT 3.30 euros
* Wiit Rated New Buy at Berenberg; PT 23 euros

>>> Call
* Dunelm Upgraded at RBC to Outperform on ‘Undemanding’ Valuation